Riskpilot← Back to searchSign inGet full accessBio Ferm AB
ABActiveOrg 5591465421Kommendörsgatan 16Medical specialists activities · NACE 8622Est. 20183 employees
Revenue 2024
SEK 10,2M
+10% vs 2023
EBITDA margin
2.2%
+252% vs 2023
Equity ratio
20.7%
Financial strength
Net profit 2024
SEK 119K
+173% vs 2023
| Revenue | SEK 10,2M | +10% |
| EBITDA | SEK 220K | +252% |
| Net profit | SEK 119K | +173% |
| Total assets | SEK 837K | +46% |
| Equity | SEK 173K | +220% |
| Employees | 3 | — |
Legal name
Bio Ferm AB
Org number
5591465421
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
24 januari 2018
Share capital
SEK 50 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av Ferm, Cecilia Helena Ferm, Georg Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Konsultverksamhet som specialist i ortopedi, idrottsmedicin samt rådgivande verksamhet inom rehab och träning. Personlig- och fysisk tränare, föreläsare. Driver friskvård, träningsevent, tränings APP på teckenspråk. PRP och stamcellsbehandlingar samt all övrig biologiska behandlingar. Försäljning av kit för stamcells behandling samt utrustning som centrifuger för plasma separering och injektions kammare för plamsa behandlingar.
Address
Kommendörsgatan 16
Email
cissi.ferm@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 120 | — | 3 465 | 9 266 | 10 214 |
| Staff expenses | — | — | −1 096 | −3 317 | −2 868 |
| EBITDA | 28 | 0 | 48 | −145 | 220 |
| Depreciation & amort. | −5 | — | −4 | −16 | −37 |
| EBIT | 23 | 0 | 44 | −161 | 183 |
| Net financials | −12 | — | −0 | −1 | −23 |
| Profit before tax | 11 | 0 | 43 | −162 | 160 |
| Tax | −0 | — | −12 | — | −41 |
| Net profit | 11 | — | 31 | −162 | 119 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 170 | — | 382 | 575 | 837 |
| Equity | 71 | — | 266 | 54 | 173 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 99 | — | 116 | 521 | 664 |
| Total debt | 99 | — | 116 | 521 | 664 |
EBITDA margin
2.2%
This company
15.8%
Market median
-86% vs market
20202024
Equity ratio
20.7%
This company
38.2%
Market median
-46% vs market
20202024
Return on equity
68.8%
This company
18.4%
Market median
+274% vs market
20202024
Net profit margin
1.2%
This company
8.1%
Market median
-85% vs market
20202024
Asset turnover
12.20×
This company
1.12×
Market median
+989% vs market
20202024
Debt / equity
3.84×
This company
0.62×
Market median
-519% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PF Chief Executive Officer | Chief Executive Officer | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2025 | |
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Board of Directors | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Bio Ferm AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Fredrik Eriksson | Chief Executive Officer | 0 companies |
| Georg Ferm | Board of Directors | 0 companies |
| Cecilia Helena Ferm | Deputy Board Member | 0 companies |
| Eva Helena Danneman | Board of Directors | 0 companies |